Korea Infused Olive Oil Market Size & Outlook, 2026-2034
Korea Infused Olive Oil Market Insights
- As per Deep Market Insights insights, the Korea Infused Olive Oil Market stood at USD 18.52 Million in 2025 and is anticipated to grow to USD 34.57 Million by 2034.
- The Korea market is expected to advance at a CAGR of 7.25% from 2026 through 2034.
- In 2025, Cooking accounted for the highest share of the market size.
- During the forecast period, Salads is set to register the highest growth, making it the most lucrative segment.
Source: DMI Analysis Company Publications, Primary Interviews.
Other Key Findings
- In 2025, Korea represented 1.19% of the overall global Infused Olive Oil Market size.
- United States is projected to lead the global Infused Olive Oil Market size by 2034.
- Across Asia Pacific, China is anticipated to hold the dominant position in market size by 2034.
- South East Asia is forecasted to expand at the fastest pace in Asia Pacific, attaining USD 71.29 Million by 2034.
Report Summary
| Report Scope | Details |
|---|---|
| Base Year for Study | 2025 |
| Study Period | 2022-2034 |
| Historical Period | 2022-2024 |
| Forecast Period | 2026-2034 |
| Market Size In 2025 | USD 18.52 Million |
| Market Size In 2034 | USD 34.57 Million |
| Largest segment | Cooking |
| Units | Revenue in USD Million |
| CAGR | 7.25% (2026-2034) |
| Segmnetation Covered | |
| |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
Korea Infused Olive Oil Market 2026-2034 (USD Million)
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cooking | XX.x | XX.x | XX.x | 7.49 | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Salads | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Marination | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Food service | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
| Total | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x | XX.x |
Source: DMI Analysis Company Publications, Primary Interviews.